ZX-8177

· Nanjing Zenshine Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZX-8177, covering 2026-01-02 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors [Phase 1]

See pricing